World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
11293
World Ranking
3967
National Ranking
1815

Agegnehu Gettie publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Agegnehu Gettie sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 135 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Agegnehu Gettie D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Agegnehu Gettie sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Agegnehu Gettie is affiliated with the Aaron Diamond AIDS Research Center in the United States. Their research primarily focuses on immunology, microbiology, and medicine with a particular emphasis on HIV research and treatment.

The scientist's work spans multiple subfields including immunology, virology, infectious diseases, radiology, nuclear medicine, imaging, and rheumatology. Their research concentrates on key topics such as HIV research and treatment, T-cell and B-cell immunology, monoclonal and polyclonal antibodies research, immune cell function and interaction, systemic lupus erythematosus research, cell adhesion molecules research, and immunotherapy and immune responses.

Notable recent papers authored or co-authored by Gettie include:

  • "Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti-HIV-1 IgG1 antibodies in vivo," 2020, Proceedings of the National Academy of Sciences
  • "Blocking α 4 β 7 integrin delays viral rebound in SHIV SF162P3-infected macaques treated with anti-HIV broadly neutralizing antibodies," 2021, Science Translational Medicine
  • "Anti-α 4 β 7 monoclonal antibody-conjugated nanoparticles block integrin α 4 β 7 on intravaginal T cells in rhesus macaques," 2020, Science Advances
  • "Mucosal immune stimulation with HSV-2 and polyICLC boosts control of viremia in SIVΔNef vaccinated rhesus macaques with breakthrough SIV infection," 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • "Effectiveness of islatravir post-exposure prophylaxis after intravenous challenge with simian immunodeficiency virus in rhesus macaques," 2025, Journal of the International AIDS Society

Gettie has published work in multiple scientific venues, including:

  • Proceedings of the National Academy of Sciences
  • Science Translational Medicine
  • Science Advances
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of the International AIDS Society

The scientist frequently collaborates with a group of peers, including James Blanchard, Brooke Grasperge, Ines Frank, Elena Martinelli, and Pengfei Wang. These collaborations have contributed to the areas of immunology, virology, and infectious disease research.

Best Publications

  • Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques

    Xia Jin;Daniel E. Bauer;Sarah E. Tuttleton;Sharon Lewin

  • Progesterone implants enhance SIV vaginal transmission and early virus load

    P A Marx;A I Spira;A I Spira;A Gettie;P J Dailey

  • Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs

    Janet M. Harouse;Agegnehu Gettie;Rei Chin How Tan;James Blanchard

  • The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable Region

    S. W. Barnett;S. Lu;I. Srivastava;S. Cherpelis

  • Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus.

    Chris J Miller;N. J. Alexander;S. Sutjipto;A. A. Lackner

  • Protection against vaginal SIV transmission with microencapsulated vaccine

    Preston A. Marx;Richard W. Compans;Agegnehu Gettie;Jay K. Staas

  • Genetic characterization of New West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop.

    Z Chen;P Telfier;A Gettie;P Reed

  • Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys.

    Zhiwei Chen;Amara Luckay;Donald L. Sodora;Paul Telfer

  • Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3).

    Janet M. Harouse;Agegnehu Gettie;Tadesse Eshetu;Rei Chin How Tan

  • Normal T-Cell Turnover in Sooty Mangabeys Harboring Active Simian Immunodeficiency Virus Infection

    Lisa A. Chakrabarti;Sharon R. Lewin;Linqi Zhang;Agegnehu Gettie

  • Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

    Zhiwei Chen;Linqi Zhang;Chuan Qin;Lei Ba

  • Temporal Analyses of Virus Replication, Immune Responses, and Efficacy in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine

    Ruth I. Connor;David C. Montefiori;James M. Binley;John P. Moore

  • Long-Acting Integrase Inhibitor Protects Macaques from Intrarectal Simian/Human Immunodeficiency Virus

    Chasity D. Andrews;William R. Spreen;Hiroshi Mohri;Lee Moss

  • Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks.

    D. L. Sodora;A. Gettie;Chris J Miller;P. A. Marx

  • Use of Inhibitors To Evaluate Coreceptor Usage by Simian and Simian/Human Immunodeficiency Viruses and Human Immunodeficiency Virus Type 2 in Primary Cells

    Yi-jun Zhang;Bernard Lou;Renu B. Lal;Agegnehu Gettie

  • Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.

    Karin J. Metzner;Xia Jin;Fred V. Lee;Agegnehu Gettie

  • Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals.

    Suganto Sutjipto;Niels C Pedersen;Chris J Miller;Murray B. Gardner

  • Isolation of a simian immunodeficiency virus related to human immunodeficiency virus type 2 from a west African pet sooty mangabey.

    P A Marx;Y Li;N W Lerche;S Sutjipto

  • DNA Vaccination with the Human Immunodeficiency Virus Type 1 SF162ΔV2 Envelope Elicits Immune Responses That Offer Partial Protection from Simian/Human Immunodeficiency Virus Infection to CD8+ T-Cell-Depleted Rhesus Macaques

    S Cherpelis;I Shrivastava;A Gettie;A Gettie;X Jin

  • Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.

    Zhiwei Chen;Agegnehu Gettie;David D. Ho;Preston A. Marx;Preston A. Marx

Frequent Co-Authors

James Blanchard
James Blanchard Tulane University
Cecilia Cheng-Mayer
Cecilia Cheng-Mayer Aaron Diamond AIDS Research Center
Preston A. Marx
Preston A. Marx Tulane University
Preston A. Marx
Preston A. Marx Tulane University
David D. Ho
David D. Ho Columbia University
Michael Piatak
Michael Piatak Leidos (United States)
James F. Blanchard
James F. Blanchard University of Manitoba
Jeffrey D. Lifson
Jeffrey D. Lifson Leidos (United States)
Melissa Pope
Melissa Pope University of Sydney
James Arthos
James Arthos National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open doors to diverse career paths. Accelerated programs offer a streamlined route for individuals aiming to advance quickly. Many professionals choose accelerated NP programs to become nurse practitioners in a shorter timeframe, providing advanced clinical expertise that complements immunology knowledge.

If you’re starting without a nursing background, online accelerated nursing programs for non nurses are a practical option. They transform non-nurses into qualified registered nurses through flexible formats, ideal for balancing studies with other commitments.

Similarly, the availability of accelerated BSN programs for non nurses caters specifically to those new to the field, offering some of the more accessible pathways into nursing while maintaining academic rigor.

For those considering entry-level clinical roles, understanding which LPN programs are easiest to get into can help identify manageable starting points in healthcare careers that provide valuable patient care experience related to immunology fields.

Best Scientists Citing Agegnehu Gettie

Trending Scientists

Recently Published Articles